Literature DB >> 12479804

Dma1 prevents mitotic exit and cytokinesis by inhibiting the septation initiation network (SIN).

David A Guertin1, Srinivas Venkatram, Kathleen L Gould, Dannel McCollum.   

Abstract

In the fission yeast Schizosaccharomyces pombe, the septation initiation network (SIN) triggers cytokinesis after mitosis. We investigated the relationship between Dma1p, a spindle checkpoint protein and cytokinesis inhibitor, and the SIN. Deletion of dma1 inactivates the spindle checkpoint and allows precocious SIN activation, while overexpressing Dma1p reduces SIN signaling. Dma1p seems to function by inhibiting the SIN activator, Plo1p kinase, since dma1 overexpression and deletion phenotypes suggest that Dma1p antagonizes Plo1p localization. Furthermore, failure to maintain high cyclin-dependent kinase (CDK) activity during spindle checkpoint activation in dma1 deletion cells requires Plo1p. Dma1p itself localizes to spindle pole bodies through interaction with Sid4p. Our observations suggest that Dma1p functions to prevent mitotic exit and cytokinesis during spindle checkpoint arrest by inhibiting SIN signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479804     DOI: 10.1016/s1534-5807(02)00367-2

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  43 in total

1.  Two-hybrid search for proteins that interact with Sad1 and Kms1, two membrane-bound components of the spindle pole body in fission yeast.

Authors:  F Miki; A Kurabayashi; Y Tange; K Okazaki; M Shimanuki; O Niwa
Journal:  Mol Genet Genomics       Date:  2003-12-04       Impact factor: 3.291

2.  NSC126188, a piperazine alkyl derivative, induces apoptosis via upregulation of RhoB in HeLa cells.

Authors:  Bo-Kyung Kim; Dong-Myung Kim; Kyung-Sook Chung; Song-Kyu Park; Shin-Jung Choi; Alexander Song; Kiho Lee; Chang-Woo Lee; Kyung-Bin Song; Gyoonhee Han; Julian Simon; Hwan Mook Kim; Misun Won
Journal:  Invest New Drugs       Date:  2010-04-30       Impact factor: 3.850

3.  Isolation of mutations that bypass the requirement of the septation initiation network for septum formation and conidiation in Aspergillus nidulans.

Authors:  Jung-Mi Kim; Ling Lu; Rongzhong Shao; Jaclyn Chin; Bo Liu
Journal:  Genetics       Date:  2006-04-19       Impact factor: 4.562

Review 4.  Safeguarding entry into mitosis: the antephase checkpoint.

Authors:  Cheen Fei Chin; Foong May Yeong
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

5.  Release from myosin V via regulated recruitment of an E3 ubiquitin ligase controls organelle localization.

Authors:  Richard G Yau; Yutian Peng; Rajeshwari R Valiathan; Shanda R Birkeland; Thomas E Wilson; Lois S Weisman
Journal:  Dev Cell       Date:  2014-03-10       Impact factor: 12.270

6.  Characterization of ypa1 and ypa2, the Schizosaccharomyces pombe orthologs of the peptidyl proyl isomerases that activate PP2A, reveals a role for Ypa2p in the regulation of cytokinesis.

Authors:  Anupama Goyal; Viesturs Simanis
Journal:  Genetics       Date:  2012-01-20       Impact factor: 4.562

7.  CK1 is required for a mitotic checkpoint that delays cytokinesis.

Authors:  Alyssa E Johnson; Jun-Song Chen; Kathleen L Gould
Journal:  Curr Biol       Date:  2013-09-19       Impact factor: 10.834

Review 8.  Spatiotemporal regulation of the Dma1-mediated mitotic checkpoint coordinates mitosis with cytokinesis.

Authors:  Sierra N Cullati; Kathleen L Gould
Journal:  Curr Genet       Date:  2019-01-02       Impact factor: 3.886

9.  Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.

Authors:  Greta L Loring; Kathryn C Christensen; Scott A Gerber; Charles Brenner
Journal:  Cell Cycle       Date:  2007-10-02       Impact factor: 4.534

10.  Functional characterization of Dma1 and Dma2, the budding yeast homologues of Schizosaccharomyces pombe Dma1 and human Chfr.

Authors:  Roberta Fraschini; Denis Bilotta; Giovanna Lucchini; Simonetta Piatti
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.